| 1 |
29615799 | Idelalisib impairs TREM-1 mediated neutrophil inflammatory responses. | 2018 Apr 3 |
1 |
| 2 |
27342398 | Idelalisib Impacts Cell Growth through Inhibiting Translation-Regulatory Mechanisms in Mantle Cell Lymphoma. | 2017 Jan 1 |
2 |
| 3 |
28254430 | Anti-tumor activity of PI3K-δ inhibitor in hematologic malignant cells: Shedding new light on resistance to Idelalisib. | 2017 Apr |
1 |
| 4 |
28418085 | Puquitinib, a novel orally available PI3Kδ inhibitor, exhibits potent antitumor efficacy against acute myeloid leukemia. | 2017 Jul |
1 |
| 5 |
26463142 | [Effects of the phosphoinostitide-3'-kinase delta inhibitor, CAL-101, in combination with Bortezomib on mantle lymophma cells and exploration of its related mechanism]. | 2015 Jun |
1 |
| 6 |
26779377 | Synergistic suppression of the PI3K inhibitor CAL-101 with bortezomib on mantle cell lymphoma growth. | 2015 Dec |
1 |
| 7 |
21803855 | The phosphoinositide 3'-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia. | 2011 Sep 29 |
1 |